In fact, in Parkinson’s patients, an increase in the expression of inflammatory chemokines/cytokines and the activation of the nuclear transcription factor NF-κB, which controls the target genes coding for proinflammatory cytokines, and adhesion molecules, chemokines, was detected as growth factors and inducible enzymes [58]. This evidence concerns the gene NFKB1 and Parkinson disease.